- $2.26bn
- $2.24bn
- $237.46m
- 70
- 12
- 69
- 49
Annual income statement for Agilysys, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 161 | 137 | 163 | 198 | 237 |
Cost of Revenue | |||||
Gross Profit | 81 | 89.4 | 102 | 121 | 144 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 195 | 158 | 156 | 185 | 222 |
Operating Profit | -34.1 | -21 | 6.32 | 12.9 | 15.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -33.9 | -21.2 | 6.51 | 15.8 | 20.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -34.1 | -21 | 6.48 | 14.6 | 86.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -34.1 | -21 | 6.48 | 14.6 | 86.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -34.1 | -23.6 | 4.64 | 12.7 | 85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.789 | -0.321 | 0.282 | 0.52 | 3.21 |